ahlam1399
09-12-2016, 01:30 PM
GSK sells anesthetics to Aspen for up to $370 million
LONDON (Reuters) - GlaxoSmithKline is to sell its portfolio of anesthetic ***** to South Africa's Aspen Pharmacare for up to 280 million pounds ($372 million) as part of a drive by the British drugmaker to focus on core therapy areas.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=Ss38f2gX5Y8:NhU-d8ln_KM:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=Ss38f2gX5Y8:NhU-d8ln_KM:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=Ss38f2gX5Y8:NhU-d8ln_KM:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=Ss38f2gX5Y8:NhU-d8ln_KM:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=Ss38f2gX5Y8:NhU-d8ln_KM:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/Ss38f2gX5Y8
LONDON (Reuters) - GlaxoSmithKline is to sell its portfolio of anesthetic ***** to South Africa's Aspen Pharmacare for up to 280 million pounds ($372 million) as part of a drive by the British drugmaker to focus on core therapy areas.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=Ss38f2gX5Y8:NhU-d8ln_KM:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=Ss38f2gX5Y8:NhU-d8ln_KM:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=Ss38f2gX5Y8:NhU-d8ln_KM:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=Ss38f2gX5Y8:NhU-d8ln_KM:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=Ss38f2gX5Y8:NhU-d8ln_KM:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/Ss38f2gX5Y8